These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35260123)

  • 1. Changing epidemiology of yellow fever virus in Oyo State, Nigeria.
    Bassey BE; Braka F; Onyibe R; Kolude OO; Oluwadare M; Oluwabukola A; Omotunde O; Iyanda OA; Tella AA; Olanike OS
    BMC Public Health; 2022 Mar; 22(1):467. PubMed ID: 35260123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The resurgence of yellow fever outbreaks in Nigeria: a 2-year review 2017-2019.
    Nomhwange T; Jean Baptiste AE; Ezebilo O; Oteri J; Olajide L; Emelife K; Hassan S; Nomhwange ER; Adejoh K; Ireye F; Nora EE; Ningi A; Bathondeli B; Tomori O
    BMC Infect Dis; 2021 Oct; 21(1):1054. PubMed ID: 34635069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019.
    Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C
    BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yellow fever control in Cameroon: where are we now and where are we going?
    Wiysonge CS; Nomo E; Mawo J; Ofal J; Mimbouga J; Ticha J; Ndumbe PM
    BMC Med; 2008 Feb; 6():3. PubMed ID: 18261201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
    Tomori O
    Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study.
    Jean K; Raad H; Gaythorpe KAM; Hamlet A; Mueller JE; Hogan D; Mengistu T; Whitaker HJ; Garske T; Hocine MN
    PLoS Med; 2021 Feb; 18(2):e1003523. PubMed ID: 33600451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urban yellow fever epidemic in western Nigeria, 1987.
    Nasidi A; Monath TP; DeCock K; Tomori O; Cordellier R; Olaleye OD; Harry TO; Adeniyi JA; Sorungbe AO; Ajose-Coker AO
    Trans R Soc Trop Med Hyg; 1989; 83(3):401-6. PubMed ID: 2617590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of yellow fever incidence in Togo between 2010 and 2020.
    Zida-Compaore WIC; Gbeasor-Komlanvi FA; Tchankoni MK; Halatoko WA; Sadio AJ; Konu YR; Gnatou GY; Koba AK; Agbonon A; Ekouevi DK
    Travel Med Infect Dis; 2022; 50():102470. PubMed ID: 36208863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccination coverage following massive emergency immunization campaigns in rural Uganda, May 2011: a community cluster survey.
    Bagonza J; Rutebemberwa E; Mugaga M; Tumuhamye N; Makumbi I
    BMC Public Health; 2013 Mar; 13():202. PubMed ID: 23497254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.
    Garske T; Van Kerkhove MD; Yactayo S; Ronveaux O; Lewis RF; Staples JE; Perea W; Ferguson NM;
    PLoS Med; 2014 May; 11(5):e1001638. PubMed ID: 24800812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
    Monath TP
    Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
    Shearer FM; Longbottom J; Browne AJ; Pigott DM; Brady OJ; Kraemer MUG; Marinho F; Yactayo S; de Araújo VEM; da Nóbrega AA; Fullman N; Ray SE; Mosser JF; Stanaway JD; Lim SS; Reiner RC; Moyes CL; Hay SI; Golding N
    Lancet Glob Health; 2018 Mar; 6(3):e270-e278. PubMed ID: 29398634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the large-scale yellow fever outbreak in Luanda, Angola, and the impact of vaccination.
    Zhao S; Stone L; Gao D; He D
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006158. PubMed ID: 29338001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of yellow fever outbreaks in a partially vaccinated population: An analysis of the effective reproduction number.
    Ferreira FCDSL; Bastos Camacho LA; Villela DAM
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010741. PubMed ID: 36108073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.